Meeting Banner
Abstract #0787

Magnetisation transfer saturation and MTR in multiple sclerosis: sensitivity to longitudinal change and clinical disability

Elizabeth York1, Rozanna Meijboom1, Michael J. Thrippleton1, Agniete Kampaite1, Maria Valdes Hernandez1, Peter Connick2, Siddharthan Chandran1,2, David P.J. Hunt1, and Adam D. Waldman1
1Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom, 2Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom


Myelin-sensitive magnetisation transfer saturation (MTsat) corrects magnetisation transfer ratio (MTR) signal variance, accounting for T1 recovery and B1 inhomogeneities, but its validity as a longitudinal imaging marker in multiple sclerosis (MS) is not yet clear. Here, we examine longitudinal change in cerebral MTsat and MTR in a cohort of people with newly diagnosed MS (n=62). MTsat, but not MTR, decreased in normal-appearing white matter over one year and was associated with clinical disability progression. In white matter lesions, both MTsat and MTR increased longitudinally. We conclude that MTsat is more sensitive to subtle myelin damage over time than MTR.

This abstract and the presentation materials are available to members only; a login is required.

Join Here